Chronic Myeloid Leukemia

CHRONIC MYELOID LEUKEMIA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials

A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP

Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates

GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?

New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records

Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.

CHRONIC MYELOID LEUKEMIA NEWS

Therapeutic Drug Monitoring Improved Incidence of Pleural Effusion With Dasatinib for CP-CML

July 19, 2021

Treating a patient that has tested positive for coronavirus.

CML: COVID-19 May Be Fatal in More Than 5% of Patients

June 11, 2021

A blood smear of chronic myeloid leukemia cells.

Response-Based Ponatinib Dosing Appears Effective in Chronic Phase Chronic Myeloid Leukemia

June 5, 2021

Chronic Myeloid Leukemia: What Your Patients Need to Know

June 2, 2021

Many clinical and ethical factors influence whether preemptive transplant would be beneficial for patients genetically predisposed to acute myeloid leukemia.

How Intermittent Fasting Affects Patients Receiving Tyrosine Kinase Inhibitors for CML

May 25, 2021

Next post in Chronic Myeloid Leukemia

Chronic Myeloid Leukemia: What Your Patients Need to Know